Kazuto Kato: the ethics of editing humanity
By Gary Humphreys,
Bulletin of the World Health Organization
| 09. 01. 2021
Photo from Kazuto Kato’s biography at
University of Oxford’s Faculty of Law
Gary Humphreys talks to Kazuto Kato about the ethical and societal challenges posed by biotechnologies that allow for the editing of the human genome.
Q: You started out working in developmental biology. How did you become interested in the field of ethics and governance of biomedicine?
A: As a student, I always had a broad interest in the societal issues related to biological science and its application and was actually a member of a student club that focused on such issues. I was also encouraged to look at issues outside the laboratory by my uncle, Professor Shuzo Nishimura, a pioneer in the field of health economics in Japan. Of course, I also had nine years at Kyoto University and four years at the University of Cambridge with Sir John Gurdon studying biology, with a focus on stem cell biology and genomics. This background has helped me navigate what is sometimes complex terrain.
Q: Given that complexity, can you start by giving our readers a simple definition of genomics...
Related Articles
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
Mike Pennington / Dolly the sheep, National
Museums of Scotland, Edinburgh / CC BY-SA 2.0
The first mammal cloned from an adult cell, Dolly the sheep, was born on July 5, 1996. She became a global star, but neither she nor British embryologist Ian Wilmut (her foster daddy) got rich, though Wilmut did eventually receive a knighthood for leading the successful team. Dolly lived a pampered life and died in 2003; her body remains on display at the National Museum...
By David Coltman, Carson Mitchell, Liam Alastair Wayde Carter, and Tommy Galfano, The Conversation | 05.12.2025
Gray wolf by Jessica Eirich via Unsplash
“I’m not a scarcity guy, I’m an abundance guy”
– Colossal co-founder and CEO Ben Lamm, The New Yorker, 4/14/25
Even the most casual consumers of news will have seen the run of recent headlines featuring the company Colossal Biosciences. On March 4, they announced with great fanfare the world’s first-ever woolly mice, as a first step toward creating a woolly mammoth. Then they topped that on April 7 by unveiling one...